BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2021 10:51:03 AM | Browse: 636 | Download: 1279
 |
Received |
|
2021-03-05 17:40 |
|
Peer-Review Started |
|
2021-03-05 17:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-27 21:27 |
|
Revised |
|
2021-04-11 05:10 |
|
Second Decision |
|
2021-05-22 14:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-22 15:24 |
|
Articles in Press |
|
2021-05-22 15:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-02 03:28 |
|
Publish the Manuscript Online |
|
2021-06-08 10:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Natsuki Ishida, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta and Ken Sugimoto |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ken Sugimoto, MD, PhD, Associate Professor, First Department of Medicine, Hamamatsu University of School of Medicine, 1-20-1 Handayama Higashi-ku Hamamatsu, Hamamatsu 431-3192, Japan. sugimken@hama-med.ac.jp |
| Key Words |
Ulcerative colitis; Tacrolimus; Albumin |
| Core Tip |
The usefulness of serum albumin as a predictor of the therapeutic effect of oral tacrolimus for ulcerative colitis was investigated. Lower albumin levels in week 2 than in week 0 after achieving trough levels of tacrolimus were shown to increase risk for failure, including colectomy and switch to biologics, within 3 mo. In these cases, changes to other treatment options, including surgical total colectomy, should be considered as soon as possible. |
| Publish Date |
2021-06-08 10:51 |
| Citation |
Ishida N, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome. World J Gastroenterol 2021; 27(22): 3109-3120 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i22/3109.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i22.3109 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
